Biochemical Engineering Special Interest Group
biological engineering professionals
07 September 2017

Biocon's insulin facility in Malaysia passes EMA inspection

Biocon’s insulin manufacturing facility in Malaysia has received a Good Manufacturing Compliance certificate from Europe’s drug regulator, giving its Malaysian subsidiary the green light to supply products manufactured at this plant to the European market. Biocon's Malaysia facility was inspected by the EMA in April 2017, stated the company. The facility, set up with an investment of $275 million, is designed to manufacture recombinant human insulin and insulin analogs for the global market. Source: The Economic Times 7/9/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).